Mai Peptide Safety Rating & Test Results

As of 2 Aug 2026, Finnrick has published 87 independent lab tests of 7 peptides from Mai Peptide: 66 passed and 21 failed under the default public standard, Purity Focus (HPLC purity at least 99.5%, fill within ±35% of the label claim). The latest test is dated 13 Jul 2026.

Finnrick ratings are recency-weighted pass percentages: newer tests count more, and vendors with thin test histories are pulled toward the peer baseline for that peptide, so a single result cannot look too certain. Samples are analyzed by independent partner laboratories and the results are published by Finnrick Analytics, which does not sell peptides and does not accept payment to alter ratings. Corrections to published data are recorded at finnrick.com/corrections.

Purchased from Mai Peptide? Submit a sample to Finnrick for free independent lab testing — results are published publicly.

Are you Mai Peptide? Finnrick offers professional testing services and a public launch program for peptide vendors.

Interactive charts, prices, and test history for this page load with JavaScript; the facts above are from Finnrick's published test database.

Mai Peptide peptides tested by Finnrick, rated under the default public methodology.
PeptideFinnrick ratingLab testsLatest test
BPC-15750%413 Jul 2026
Cagrilintide58%513 Jul 2026
GHK-Cu89%101 Jul 2026
Ipamorelin77%728 Apr 2026
Retatrutide85%3410 Jul 2026
Tesamorelin52%513 Jul 2026
Tirzepatide65%221 Jul 2026